Torrent Pharma rebounded from its 200-day EMA support in June 2025. The stock broke out from a falling trendline resistance.

India's Torrent Pharmaceuticals said on Sunday it will acquire a 46.39% controlling stake in smaller peer JB Chemicals and ...

In a mega deal in the Indian pharmaceutical sector, Torrent Pharmaceuticals has announced plans to acquire a 49.18% ...

The deal grants Torrent Pharma access to a thriving pharmaceutical business. JB Pharma makes drugs for gastroenterology, ...

Torrent Pharma’s ₹25,689-crore acquisition of JB Chemicals boosts its chronic portfolio and expands its global reach. But ...

The deal is expected to strengthen Torrent's market share in the Indian pharmaceutical market and diversify its platform into ...

Torrent Pharmaceuticals Limited and global investment firm KKR on Sunday announced that Torrent has entered into definitive ...

Torrent has signed definitive agreements to acquire stake in JB Pharma at an equity valuation of Rs256.89bn ($3bn) on a fully ...

Torrent Pharmaceuticals Ltd has announced the acquisition of a controlling stake in JB Chemicals & Pharmaceuticals Ltd from ...

Torrent Pharma makes a bold ₹18,000 crore move to acquire JB Chemicals, signalling a strategic comeback and consolidation ...

Torrent said on Sunday that it would acquire a controlling stake in JB Pharma from global investment firm KKR, at an equity ...

JB Chemicals already has an established domestic business, with 58% of its overall sales coming from the domestic market.